NANOVIRICIDES, INC.

NNVC

NANOVIRICIDES, INC.

NNVC

Insider Sentiment (TTM):

Last Purchase:2015-11-11Last Sale:2013-10-21Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,884,902Shares Outstanding:21,609,488Institutional Ownership Pct.:8.72%

Earnings Market Reaction:

Filing Date:2026-05-15Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Nonrelated Party	-0	-0	0	0	0	-0	1	0	0	0	0	0
Related Party	-0	0	1	0	-0	-0	1	1	-0	0	0	0
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	3	5	1	2	3	4	4	5	3	5	7	8
Prepaid Expense Current	0	0	0	0	0	0	0	0	0	0	0	0
Assets Current	3	5	1	2	3	4	4	5	4	5	7	8
Property Plant And Equipment Net	7	7	7	7	7	7	7	8	8	8	8	8
Intangible Assets Net Excluding Goodwill	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets
Assets	10	12	8	9	10	12	12	13	11	13	15	17
Other Assets	-	-	-	-	-	-	-	-	-	-	-	0
Liabilities And Stockhold…
Liabilities
Accrued Liabilities Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	1	1	1	1	1	1	2	1	1	1	1	1
Other Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	-	2
Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	2	-
Stockholders Equity
Liabilities	-	-	-	-	-	-	-	1	1	1	2	2
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	164	164	158	156	156	155	153	151	148	148	146	146
Retained Earnings Accumulated Deficit	-155	-153	-151	-149	-147	-145	-143	-139	-137	-135	-133	-131
Stockholders Equity	9	11	7	8	9	10	10	11	11	12	13	15
Liabilities And Stockholders Equity	10	12	8	9	10	12	12	13	11	13	15	17
Series A Convertible Preferred Stock	0	0	1	1	0	0	1	1	0	0	1	1
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	150	150	150	150	150	150	150
Common Stock Shares Issued	22	22	18	17	16	16	14	13	12	12	12	12
Shares Outstanding	22	22	18	17	16	16	14	13	12	12	12	12

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-13.38%	-14.79%	-31.69%	14.56%	-4.85%	50.49%	-6.76%	-10.14%	2.70%	-	-	-
2025	11.94%	11.94%	-10.45%	-5.93%	-20.00%	-3.70%	17.56%	5.34%	20.61%	7.75%	-10.56%	-12.68%
2024	-11.94%	-16.42%	-14.93%	-5.13%	17.09%	-3.42%	48.33%	-2.78%	16.67%	2.07%	-15.17%	2.07%
2023	-	-	-	-	-	-	-	-	-	-5.79%	-0.83%	-15.70%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.17	4.43	1.06	1.28	2.27	3.44	2.48	3.66	4.32	5.59	7.53	15.81
Quick Ratio	3.02	4.31	0.95	1.19	2.12	3.34	2.37	3.53	4.00	5.52	7.35	15.25
Working Capital	2.31M	4.10M	70.18K	364.19K	1.53M	2.89M	2.41M	3.61M	2.70M	4.37M	6.19M	7.91M
Leverage & Debt
Debt to Equity	0.12	0.11	0.16	0.17	0.14	0.11	0.16	0.12	0.08	0.08	0.19	0.14
Interest Coverage TTM	-	-56,339.72	-27,585.56	-32,186.73	-33,112.09	-190.70	-152.91	-85.49	-98.39	-191.22	-249.24	-4,767.31
Debt Ratio	0.10	0.10	0.14	0.15	0.12	0.10	0.14	0.11	0.07	0.07	0.16	0.12
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.37	-0.42	-0.48	-0.63	-0.61	-0.64	-0.69	-0.70	-0.81	-0.80	-0.77	-0.74
Free Cash Flow Per Share TTM	-0.34	-0.37	-0.44	-0.56	-0.52	-0.58	-0.58	-0.55	-0.54	-0.53	-0.51	-0.50
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-16.82%	-11.17%	-14.04%	14.14%	2.30%	0.09%	5.18%	-3.43%	39.86%	35.83%	27.21%	5.94%
EPS Growth (1Y)	-38.31%	-34.79%	-30.98%	-10.37%	-24.81%	-19.32%	-10.13%	-5.42%	38.15%	34.26%	25.84%	5.11%
Valuation Metrics
P/E TTM	-2.43	-2.70	-3.01	-2.24	-1.93	-2.23	-2.18	-2.46	-1.44	-1.28	-1.75	-1.56
P/B TTM	2.15	2.03	3.40	2.82	2.12	2.01	2.04	1.78	1.28	0.96	1.21	0.90
Market Cap	19.66M	22.43M	24.43M	21.16M	18.75M	20.84M	20.57M	20.42M	13.66M	11.98M	15.70M	13.37M
Enterprise Value	16.45M	17.28M	23.30M	19.60M	16.21M	16.88M	16.71M	15.62M	10.41M	6.74M	10.23M	5.22M
Calculated Values
Free Cash Flow TTM	-7.37M	-7.43M	-7.57M	-8.54M	-8.40M	-8.40M	-7.93M	-6.47M	-6.39M	-6.20M	-5.92M	-5.82M
Net Debt	-3.21M	-5.15M	-1.13M	-1.56M	-2.54M	-3.96M	-3.87M	-4.80M	-3.26M	-5.25M	-5.47M	-8.15M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2015-11-11Purchase

Owner: Boniuk, Milton

Title: -

Shares: 25,000

Price/Share: $1.20

Value: $30,000.00

Shares Owned: 150,000

Relationship: Director

Ownership: Indirect

2015-10-22Purchase

Owner: Boniuk, Milton

Title: -

Shares: 14,640

Price/Share: $1.30

Value: $19,032.00

Shares Owned: 125,000

Relationship: Director

Ownership: Indirect

2015-09-11Purchase

Owner: Boniuk, Milton

Title: -

Shares: 50,000

Price/Share: $1.02

Value: $51,000.00

Shares Owned: 100,000

Relationship: Director

Ownership: Indirect

2015-08-26Purchase

Owner: Boniuk, Milton

Title: -

Shares: 50,000

Price/Share: $1.05

Value: $52,500.00

Shares Owned: 1,705,391

Relationship: Director

Ownership: Direct

2015-08-21Purchase

Owner: Boniuk, Milton

Title: -

Shares: 29,853

Price/Share: $1.25

Value: $37,316.25

Shares Owned: 1,655,391

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2015-11-11	Boniuk, Milton	Director	-	Indirect	Purchase	25,000	1.20	$30,000.00	150,000	4
2015-10-22	Boniuk, Milton	Director	-	Indirect	Purchase	14,640	1.30	$19,032.00	125,000	4
2015-09-11	Boniuk, Milton	Director	-	Indirect	Purchase	50,000	1.02	$51,000.00	100,000	4
2015-08-26	Boniuk, Milton	Director	-	Direct	Purchase	50,000	1.05	$52,500.00	1,705,391	4
2015-08-21	Boniuk, Milton	Director	-	Direct	Purchase	29,853	1.25	$37,316.25	1,655,391	4
2015-07-08	Boniuk, Milton	Director	-	Indirect	Purchase	50,000	1.58	$79,000.00	50,000	4
2015-06-22	Boniuk, Milton	Director	-	Direct	Purchase	43,472	1.90	$82,596.80	1,605,391	4
2015-06-16	Boniuk, Milton	Director	-	Direct	Purchase	42,247	1.99	$84,071.53	1,555,391	4
2015-05-20	Boniuk, Milton	Director	-	Direct	Purchase	25,000	1.60	$40,000.00	1,505,391	4
2015-05-08	Boniuk, Milton	Director	-	Direct	Purchase	25,000	1.75	$43,750.00	1,455,391	4
2015-01-13	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Purchase	10,000	2.68	$26,800.00	2,074,918	4
2015-01-09	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Purchase	4,000	2.58	$10,320.00	2,048,918	4
2015-01-06	Boniuk, Milton	Director	-	Direct	Purchase	25,000	2.60	$65,000.00	1,430,391	4/A
2014-12-15	Boniuk, Milton	Director	-	Direct	Purchase	25,000	2.70	$67,500.00	1,405,391	4
2014-12-09	Boniuk, Milton	Director	-	Direct	Purchase	25,000	3.00	$75,000.00	1,380,391	4
2014-12-04	Boniuk, Milton	Director	-	Direct	Purchase	25,000	2.60	$65,000.00	1,430,391	4
2014-11-07	Boniuk, Milton	Director	-	Indirect	Purchase	380,954	0.00	$0.00	752,382	4
2014-10-01	Boniuk, Milton	Director	-	Direct	Purchase	19,700	3.10	$61,070.00	758,963	4
2014-08-25	Vyas, Meeta	Officer	Chief Financial Officer	Direct	Purchase	21,429	3.50	$75,001.50	147,021	4
2014-08-25	Diwan, Anil	Director,Officer,TenPercentOwner	President	Indirect	Purchase	28,571	3.50	$99,998.50	2,044,918	4
2014-07-17	Boniuk, Milton	Director	-	Direct	Purchase	28,572	3.50	$100,002.00	658,963	4
2014-02-20	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Purchase	15,000	3.80	$57,000.00	2,016,347	4
2013-10-21	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Sale	142,000	5.29	$751,180.00	1,824,286	4
2013-09-12	Boniuk, Milton	Director	-	Direct	Purchase	571,428	3.50	$1,999,998.00	658,571	4
2013-03-06	Seymour, Eugene	Director,Officer	Chief Executive Officer	Direct	Purchase	25,000	0.69	$17,250.00	6,025,000	4
2013-03-04	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Sale	147,000	0.50	$73,500.00	6,379,200	4
2013-03-04	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Purchase	147,000	0.50	$73,500.00	6,379,200	4/A
2013-03-01	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Purchase	100,000	0.49	$49,000.00	6,232,200	4/A
2013-03-01	Diwan, Anil	Director,Officer,TenPercentOwner	President	Direct	Sale	100,000	0.49	$49,000.00	6,232,200	4
2013-01-30	Theracour, Pharma, Inc.	TenPercentOwner	-	Direct	Sale	39,000	0.50	$19,500.00	33,321,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

8.72%

Inst. Shares: 1,884,902

Shares Outstanding: 21,609,488

2025-12-31

15.65%

Inst. Shares: 3,106,500

Shares Outstanding: 19,850,080

2025-09-30

8.35%

Inst. Shares: 1,427,220

Shares Outstanding: 17,082,425

2025-06-30

8.37%

Inst. Shares: 1,265,061

Shares Outstanding: 15,116,548

2025-03-31

8.99%

Inst. Shares: 1,441,430

Shares Outstanding: 16,026,318

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,884,902	21,609,488	8.72%
2025-12-31	3,106,500	19,850,080	15.65%
2025-09-30	1,427,220	17,082,425	8.35%
2025-06-30	1,265,061	15,116,548	8.37%
2025-03-31	1,441,430	16,026,318	8.99%
2024-12-31	1,377,943	14,572,042	9.46%
2024-09-30	1,318,087	13,715,959	9.61%
2024-06-30	1,313,147	11,871,054	11.06%
2024-03-31	1,088,301	11,779,579	9.24%
2023-12-31	1,094,385	11,745,906	9.32%
2023-09-30	1,107,236	11,718,791	9.45%
2023-06-30	1,135,841	11,626,220	9.77%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

NANOVIRICIDES, INC. (NNVC) — SEC Financial Statements & Analysis

NANOVIRICIDES, INC. (NNVC) is a pharmaceutical preparations company, incorporated in DE. NANOVIRICIDES, INC. trades on NYSE as: NNVC. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), NANOVIRICIDES, INC. reported a Debt-to-Equity ratio of 0.12x, a Price-to-Book (P/B) ratio of 2.15x (TTM), at a market cap of $19.66M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.12x
P/B TTM: 2.15x
Market Cap: $19.66M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is NANOVIRICIDES, INC. in?

NANOVIRICIDES, INC. (NNVC) operates in the Pharmaceutical Preparations industry.

What is NNVC's market cap?

NANOVIRICIDES, INC. (NNVC) has a market capitalization of $19.66M as of 2026-03-31.

What exchange does NNVC trade on?

NANOVIRICIDES, INC. (NNVC) trades on the NYSE.

Where is NANOVIRICIDES, INC. incorporated?

NANOVIRICIDES, INC. is incorporated in DE.